Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UK-432,097 in COPD
NCT00430300Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Jan 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of UK-432097 in chronic obstructive pulmonary disease (COPD), sponsored by Pfizer. Started Jan 2007; status: terminated.
02
Drugs
UK-432097
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00430300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430300.